{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:20:45Z","timestamp":1782181245700,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T00:00:00Z","timestamp":1299283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00392-011-0298-z","type":"journal-article","created":{"date-parts":[[2011,3,6]],"date-time":"2011-03-06T14:57:56Z","timestamp":1299423476000},"page":"683-690","source":"Crossref","is-referenced-by-count":20,"title":["Successful treatment of thromboangiitis obliterans (Buerger\u2019s disease) with immunoadsorption: results of a pilot study"],"prefix":"10.1007","volume":"100","author":[{"given":"Gert","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Stangl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klein-Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Stangl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Laule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Enke-Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,5]]},"reference":[{"key":"298_CR1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","volume":"343","author":"JW Olin","year":"2000","unstructured":"Olin JW (2000) Thromboangiitis obliterans (Buerger\u2019s disease). N Engl J Med 343:864\u2013869","journal-title":"N Engl J Med"},{"key":"298_CR2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF02015288","volume":"5","author":"JL Mills","year":"1991","unstructured":"Mills JL, Porter JM (1991) Buerger\u2019s disease (thromboangiitis obliterans). Ann Vasc Surg 5:570\u2013572","journal-title":"Ann Vasc Surg"},{"key":"298_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0895-7967(03)00023-1","volume":"16","author":"JL Mills","year":"2003","unstructured":"Mills JL (2003) Buerger\u2019s disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 16:179\u2013189","journal-title":"Semin Vasc Surg"},{"key":"298_CR4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.6045.1165","volume":"2","author":"GA McLoughlin","year":"1976","unstructured":"McLoughlin GA, Helsby CR, Evans CC, Chapman DM (1976) Association of HLA-A9 and HLA-B5 with Buerger\u2019s disease. Br Med J 2:1165\u20131166","journal-title":"Br Med J"},{"key":"298_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1399-0039.1979.tb00835.x","volume":"14","author":"P Moerloose de","year":"1979","unstructured":"de Moerloose P, Jeannet M, Mirimanoff P, Bouvier CA (1979) Evidence for an HLA-linked resistance gene in Buerger\u2019s disease. Tissue Antigens 14:169\u2013173","journal-title":"Tissue Antigens"},{"key":"298_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-199801000-00004","volume":"315","author":"J Eichhorn","year":"1998","unstructured":"Eichhorn J, Sima D, Lindschau C et al (1998) Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 315:17\u201323","journal-title":"Am J Med Sci"},{"key":"298_CR7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-3083.1998.00430.x","volume":"48","author":"KS Halacheva","year":"1998","unstructured":"Halacheva KS, Manolova IM, Petkov DP, Andreev AP (1998) Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger\u2019s disease). Scand J Immunol 48:544\u2013550","journal-title":"Scand J Immunol"},{"key":"298_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0741-5214(99)70273-9","volume":"29","author":"M Kobayashi","year":"1999","unstructured":"Kobayashi M, Ito M, Nakagawa A, Nishikimi N, Nimura Y (1999) Immunohistochemical analysis of arterial wall cellular infiltration in Buerger\u2019s disease. J Vasc Surg 29:451\u2013458","journal-title":"J Vasc Surg"},{"key":"298_CR9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10016-005-9436-2","volume":"20","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Nishikimi N, Komori K (2006) Current pathological and clinical aspects of Buerger\u2019s disease in Japan. Ann Vasc Surg 20:148\u2013156","journal-title":"Ann Vasc Surg"},{"key":"298_CR10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/000331978203301003","volume":"33","author":"SM Gulati","year":"1982","unstructured":"Gulati SM, Madhra K, Thusoo TK, Nair SK, Saha K (1982) Autoantibodies in thromboangiitis obliterans (Buerger\u2019s Disease). Angiology 33:642\u2013651","journal-title":"Angiology"},{"key":"298_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1196\/annals.1361.108","volume":"1051","author":"AY Hershko","year":"2005","unstructured":"Hershko AY, Naparstek Y (2005) Removal of pathogenic autoantibodies by immunoadsorption. Ann N Y Acad Sci 1051:635\u2013646","journal-title":"Ann N Y Acad Sci"},{"key":"298_CR12","first-page":"59","volume":"105","author":"F Moreso","year":"1995","unstructured":"Moreso F, Poveda R, Gil-Vernet S et al (1995) Therapeutic immunoadsorption in Goodpasture disease. Med Clin 105:59\u201361","journal-title":"Med Clin"},{"key":"298_CR13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","volume":"159","author":"L Psaridi-Linardaki","year":"2005","unstructured":"Psaridi-Linardaki L, Trakas N, Mamalaki A, Tzartos SJ (2005) Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen specific therapeutic strategy. J Neuroimmunol 159:183\u2013191","journal-title":"J Neuroimmunol"},{"key":"298_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2004.029660","volume":"64","author":"GH Stummvoll","year":"2005","unstructured":"Stummvoll GH, Aringer M, Smolen JS et al (2005) IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study. Ann Rheum Dis 64:1015\u20131021","journal-title":"Ann Rheum Dis"},{"key":"298_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(89)91672-3","volume":"1","author":"A Palmer","year":"1989","unstructured":"Palmer A, Taube D, Welsh K, Bewick M, Gjorstrup P, Thick M (1989) Removal of anti HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 1:10\u201312","journal-title":"Lancet"},{"key":"298_CR16","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1161\/01.CIR.95.8.1994","volume":"95","author":"WV D\u00f6rffel","year":"1997","unstructured":"D\u00f6rffel WV, Felix SB, Wallukat G et al (1997) Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95:1994\u20131997","journal-title":"Circulation"},{"key":"298_CR17","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","volume":"35","author":"SB Felix","year":"2000","unstructured":"Felix SB, Staudt A, D\u00f6rffel WV et al (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590\u20131598","journal-title":"J Am Coll Cardiol"},{"key":"298_CR18","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/01.CIR.103.22.2681","volume":"103","author":"A Staudt","year":"2001","unstructured":"Staudt A, Sch\u00e4per F, Stangl V et al (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681\u20132682","journal-title":"Circulation"},{"key":"298_CR19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2006.03.022","volume":"152","author":"A Staudt","year":"2006","unstructured":"Staudt A, Hummel A, Ruppert J et al (2006) Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 152:e1\u2013e6","journal-title":"Am Heart J"},{"key":"298_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00392-008-0689-y","volume":"97","author":"II M\u00fcller","year":"2008","unstructured":"M\u00fcller II, Klingel K, Nikolaev VO, Jahns R, Gawaz MP, Weig HJ (2008) Immunoadsorption in a 40\u00a0year old man with dilated cardiomyopathy and underlying active myocarditis. Clin Res Cardiol 97:787\u2013790","journal-title":"Clin Res Cardiol"},{"key":"298_CR21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00392-010-0162-6","volume":"99","author":"D Bulut","year":"2010","unstructured":"Bulut D, Scheeler M, Wichmann T, B\u00f6rgel J, Miebach T, M\u00fcgge A (2010) Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 99:633\u2013638","journal-title":"Clin Res Cardiol"},{"key":"298_CR22","first-page":"102","volume":"29","author":"E Minar","year":"2009","unstructured":"Minar E (2009) Critical limb ischaemia. H\u00e4mostasiologie 29:102\u2013109","journal-title":"H\u00e4mostasiologie"},{"key":"298_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpain.2009.06.007","volume":"11","author":"JT Farrar","year":"2010","unstructured":"Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A (2010) The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. J Pain 11:109\u2013118","journal-title":"J Pain"},{"key":"298_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/000331979905000303","volume":"50","author":"M Cachovan","year":"1999","unstructured":"Cachovan M, Rogatti W, Woltering F et al (1999) Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudication. Angiology 50:193\u2013200","journal-title":"Angiology"},{"key":"298_CR25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10067-008-0843-y","volume":"27","author":"KI Paraskevas","year":"2008","unstructured":"Paraskevas KI (2008) Treatment-of-choice for Buerger\u2019s disease (thromboangiitis obliterans): still an unresolved issue. Clin Rheumatol 27:547","journal-title":"Clin Rheumatol"},{"key":"298_CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10067-008-0883-3","volume":"27","author":"H Tavakoli","year":"2008","unstructured":"Tavakoli H, Salimi J, Rashidi A (2008) Reply: \u201cTreatment-of-choice for Buerger\u2019s disease (thromboangiitis obliterans): still an unresolved issue\u201d. Clin Rheumatol 27:813","journal-title":"Clin Rheumatol"},{"key":"298_CR27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0140-6736(90)90346-7","volume":"335","author":"JN Fiessinger","year":"1990","unstructured":"Fiessinger JN, Sch\u00e4fer M (1990) Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet 335:555\u2013557","journal-title":"Lancet"},{"key":"298_CR28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0741-5214(98)70022-9","volume":"28","author":"JM Isner","year":"1998","unstructured":"Isner JM, Baumgartner I, Rauh G et al (1998) Treatment of thromboangiitis obliterans (Buerger\u2019s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28:964\u2013973","journal-title":"J Vasc Surg"},{"key":"298_CR29","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.106.644203","volume":"114","author":"K Miyamoto","year":"2006","unstructured":"Miyamoto K, Nishigami K, Nagaya N et al (2006) Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 114:2679\u20132684","journal-title":"Circulation"},{"key":"298_CR30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1253\/circj.71.1187","volume":"71","author":"Y Saito","year":"2007","unstructured":"Saito Y, Sasaki K, Katsuda Y et al (2007) Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger\u2019s disease. Circ J 71:1187\u20131192","journal-title":"Circ J"},{"key":"298_CR31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1076029608319882","volume":"15","author":"Z Boda","year":"2009","unstructured":"Boda Z, Udvardy M, R\u00e1zs\u00f3 K et al (2009) Stem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger\u2019s disease. Clin Appl Thromb Hemost 15:552\u2013560","journal-title":"Clin Appl Thromb Hemost"},{"key":"298_CR32","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/stem.207","volume":"27","author":"A Kawamoto","year":"2009","unstructured":"Kawamoto A, Katayama M, Handa N et al (2009) Intramuscular transplantation of G-CSF-mobilized CD34+ cells in patients with critical limb ischemia: a phase I\/IIa, multicenter, single-blind, dose-escalation clinical trial. Stem Cells 27:2857\u20132864","journal-title":"Stem Cells"},{"key":"298_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/bmt.2009.102","volume":"45","author":"RK Burt","year":"2010","unstructured":"Burt RK, Testori A, Oyama Y et al (2010) Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 45:111\u2013116","journal-title":"Bone Marrow Transplant"},{"key":"298_CR34","first-page":"40","volume":"14","author":"R Rivera","year":"1973","unstructured":"Rivera R (1973) Roentgenographic diagnosis of Buerger\u2019s disease. J Cardiovasc Surg 14:40\u201346","journal-title":"J Cardiovasc Surg"},{"key":"298_CR35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/kel388","volume":"46","author":"X Pu\u00e9chal","year":"2007","unstructured":"Pu\u00e9chal X, Fiessinger JN (2007) Thromboangiitis obliterans or Buerger\u2019s disease: challenges for the rheumatologist. Rheumatology 46:192\u2013199","journal-title":"Rheumatology"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0298-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-011-0298-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0298-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:55:33Z","timestamp":1712274933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-011-0298-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,5]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1007\/s00392-011-0298-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,5]]}}}